| Journal | Annals of palliative medicine |
| Study Type | Randomized Trial |
| Population | Human participants |
Cancer pain remains inadequately controlled in many patients despite available opioid and adjuvant therapies, driving interest in cannabis as an additional tool. This narrative review synthesizes recent evidence on cannabis efficacy for cancer-related pain, providing clinicians with updated guidance on an increasingly available therapeutic option.
This narrative review examined 20 studies published between 2018-2025 investigating cannabis for cancer-related pain management. The authors searched major databases using comprehensive terms covering cannabinoids, THC/CBD, and cancer pain. While the summary doesn’t detail specific efficacy findings, this represents an effort to consolidate emerging evidence on cannabis in oncology pain management during a period of rapid legal and clinical evolution. The review’s scope covers the growing body of literature as medical marijuana became legal in 40 US states.
“I see this type of narrative synthesis as helpful for staying current, though I always want to see the actual efficacy data and study quality assessments. Cancer pain is complex and multifactorial – cannabis may help some patients, but we need rigorous evidence to guide optimal dosing and patient selection.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
This narrative review examined the efficacy of medical marijuana for cancer pain management, though specific efficacy outcomes are not detailed in the provided summary. The increasing legalization across 40 US states and ongoing research interest suggests potential clinical utility, but variability in patient responses remains a key consideration for clinicians.
What are the main cannabinoids used for cancer pain treatment?
The primary cannabinoids studied for cancer pain are THC (tetrahydrocannabinol) and CBD (cannabidiol), as indicated by the search terms used in this review. These compounds work through different mechanisms on pain pathways, with THC providing psychoactive effects and CBD offering non-psychoactive therapeutic benefits.
How does medical marijuana work for cancer pain relief?
Medical marijuana affects pain pathways in the body, though the exact mechanisms remain an active area of investigation according to this review. The cannabinoids interact with the endocannabinoid system, which plays a role in pain perception and modulation in cancer patients.
What should clinicians know about patient variability with medical marijuana?
The review identifies variability in patient responses as a key area of investigation, suggesting that not all cancer patients respond uniformly to medical marijuana treatment. This variability necessitates individualized treatment approaches and careful monitoring when prescribing medical marijuana for cancer pain management.
What is the current legal status of medical marijuana for cancer patients?
Medical marijuana is currently legal in 40 US states and the District of Columbia, making it an accessible option for many cancer patients. However, clinicians should be aware of their specific state regulations and institutional policies when considering medical marijuana as a treatment option for cancer-related pain.
